Evidence map›Paper›PMID 36742045›Full record

ArticleFrontiers in neurology2022

Genetic removal of synaptic Zn

Emily C Vogler, Matthew Mahavongtrakul, Kristianna Sarkan, Ryan C Bohannan, Silvina Catuara-Solarz, Jorge Busciglio

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Genetic deletion of zinc transporter ZnTFrontiers in molecular neuroscience · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Emily C VoglerDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States.
Matthew MahavongtrakulDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States.
Kristianna SarkanDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States.
Ryan C BohannanDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States.
Silvina Catuara-SolarzDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States.
Jorge BusciglioDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States.
University of California, Irvine · US

Funding

The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
NIA NIH HHS RF1 AG056850
6 · The paper itself

Abstract

Vesicular Zn

Indexed as

Alzheimer's disease (AD)hippocampusneurodegenerationneuronal hyperactivityneurotrophic signalingsynaptic zinczinc transporterZnT3

Identifiers

PMID36742045
PMCPMC9895830
OpenAlexW4317521304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.